Autotest Market Size To Reach $ 8.11 Billion By 2027, According To Brandessence Market Research

LONDON, December 6, 2021 / PRNewswire / – According to the Brandessence market research “Global Self-Testing Market: Global Size, Trends, Competitive Analysis, History and Forecast, 2021-2027“, the size of the self-test market is estimated at $ 5.96 billion in 2020 and should reach $ 8.11 billion by 2027 with a CAGR of 4.50% over the forecast period, promising a robust forecast.

The availability of self-testing for covid, the increased burden of chronic diseases like diabetes, and the increased awareness of self-testing for conditions like HIV remain the main drivers of the growth of the auto market. -screening. Self-testing is also becoming a widespread mechanism, as the covid-19 pandemic continues to require social distancing and increases the need for self-testing and telemedicine for patients around the world. TakeMeHome, a public-private partnership was launched in the United States in 2020 to increase access to HIV testing for individual high-risk groups. More than 18 states in the United States have participated in the partnership to provide home care to people who have remained largely lackluster in their testing abilities. Likewise, the Food and Drug Administration (FDA) also approved a self-test for covid-19 in November 2020. Increased progress in testing and increased awareness of the importance of early testing for chronic diseases like diabetes, HIV, among others, remain notable. engines of growth.

Request a sample report: @ https://brandessenceresearch.com/requestSample/PostId/1382

Automatic testing market segmentation:

By product:

  • Diagnostic kits
  • Diagnostic device
  • Diagnostic strips

By use:

By application:

  • Cholesterol and triglyceride tests
  • Diabetes and blood sugar tests
  • Blood pressure test
  • Diabetes and blood sugar test
  • Pregnancy test
  • Urinary tract infection test
  • STD / STI test Fertility test
  • Ovulation test Cancer test
  • Transaminase test
  • Thyroid test Menopause test
  • Celiac intolerance or disease test
  • Allergy test
  • Anemia test

By sample:

  • Urine
  • Some blood
  • Saddles
  • Oral swabs
  • Other

By the end user:

  • Hospital pharmacies
  • Pharmacies
  • E-commerce

In addition to the essential use of the self-test in the diagnosis of disease, these offer various advantages over conventional tests. These include fast, cost effective, convenient and diverse application. Many self-test kits require a small procedure, which provides flexibility in how the test is performed, whether with oral fluid, urine, or collected specimens.

Because of their essential applications, the self-test is used for the diagnosis of a wide range of diseases and medical conditions. The main ones include pregnancy, infertility, STIs, HIV, diabetes, among others. In addition, the demand for self-tests for other conditions like cancer, hepatitis C, vision disturbances, urinary tract infections and regular blood pressure tests also remains widespread in the general population. Increased efficiency, cost-effectiveness and convenience remain the primary drivers of the growth of self-test kits globally.

Self-test market: key trends

Diabetes remains one of the main drivers of self-testing around the world. Diabetes can lead to a variety of other major medical conditions including vision loss, amputations, and more. In addition, according to the World Health Organization (WHO), the number of diabetics increased from 108 million in 1980 to 422 million in 2014. While diabetes has remained a prevalent disease in high-income countries, it is ‘is prevalent in low income countries, and also middle income countries. It is quickly becoming a major cause of blindness, heart attacks, kidney failure, stroke, and lower limb amputation. Between 2000 and 2016, diabetes led to a 5% increase in premature mortality. In addition, in 2019, diabetes became the ninth leading cause of death for 1.5 million people worldwide. The home test is ideal for patients with diabetes who can measure their progress regularly and track it based on physical activity, medications, diet, and regular screening. The growing number of diabetic patients worldwide, the heightened awareness of the disease in developing countries, and the tremendous promise of self-testing mechanisms promise tremendous growth for the self-testing market.

Chronic diseases like HIV continue to plague the American population. The Center for Disease Control and Prevention estimates that approximately 14% of the HIV-positive American population is unaware of their condition. In addition, the total number of people living with the disease stands at over 1.2 million people. In addition, the new incidences of the disease amount to approximately 38,000 new cases each year. Chronic diseases like colon cancer, HIV, diabetes, among others, also require regular screening and testing. The increasing demand for chronic disease screening tests for diabetes, HIV and cancer also remains a promising growth driver in the self-testing market.

Methodology request for this report: https://brandessenceresearch.com/requestMethodology/PostId/1382

Telemedicine continues to emerge to reach new patient groups around the world. Covid-19 has accelerated the growth of medicine in many new parts of the world. However, its main attraction lies in its ability to reach patients in rural and remote areas. In countries like the United States, rural patients have remained largely affected by conditions such as disability and chronic disease. In addition, disability and limited access to healthcare remain major challenges for this population. The rural population continues to witness an increased closure of health facilities and support services such as pharmacies due to increasing urbanization. This is a well-recognized trend in the United States, while it remains an important trend globally. The growing trend towards self-testing due to increasing efficiency and increased awareness of reaching patients in rural areas in key regions like North America remain promising growth drivers in the self-test market.

Automated Testing Market: Latest News and Insights

In November 2020, the US FDA approved the emergency clearance of the Lucira Covid-19 all-in-one test kit. The test kit deploys a real-time molecule or loop-mediated amplification reaction via a unique testing mechanism to detect the novel coronavirus. The test should be offered at a reasonable price at $ 50. With measures to ensure everyone receives testing for free, this test is likely to reach all who need it, while securing a strong business promise for growth.

Hardvard Faculty of Medicine researchers, Tianjin University, and mcgill university tested on-chip diagnostic technology for the direct detection of SARS-CoV-2N protein in nasal samples. The technology provides rapid sampling of coronavirus patients and, in testing, has outperformed all other testing methods currently deployed. Rapid results remain a major concern for coronavirus patients and other stakeholders, including governments around the world. The technology promises a new leap in self-testing, as well as in ending the global pandemic.

Automated Testing Market: Competitive Analysis

Due to the growing demand for self-testing, the market remains a fragmented, competitive and innovative landscape. Growing demand for new testing methods for a wide range of diseases and the increased penetration of new strains of coronavirus continue to drive demand for self-testing. The major players in the self-testing market remain focused on acquisitions, mergers and collaboration to gain larger market share globally. Some key players in the global self-testing market are

  • PRIMA Lab SA.
  • Biolytic Laboratories Inc.
  • Self-diagnosis OÜ
  • OraSure Technologies, Inc
  • Nectar Lifesciences Limited
  • Pyramid companies
  • Cardinal Health
  • Accuquik
  • Geratherm Medical SA
  • Johnson & johnson
  • B. Braun Holding GmbH

North America

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • The rest of europe

Asia Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

South America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Egypt
  • South Africa
  • Rest of the MEA

Get the full research report: https://brandessenceresearch.com/healthcare/self-testing-industry-analysis

Associated reports:

i-Factor: live market intelligence platform

I-Factor is our guaranteed seal to keep our clients always ahead of the competition. This knowledge platform provides real-time updates on key economic indicators, competitive landscape, changing demand, trends, personalized regional information, and more. The platform visualizes key data points to help make decision making agile, trustworthy and holistic. Sign up for a free trial here @ https://brandessenceresearch.com/i-factor/login/userRegister

Brandessence Market Research & Consulting Pvt Ltd.

Brandessence Market Research publishes market research reports and business information produced by highly trained and experienced industry analysts. Our research reports are available across a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, construction, chemicals and more. The Brand Essence Market Research report will be best suited for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs and directors, governments, agencies, organizations and doctors. Students. We have a delivery center at Pune, India and our sales office is at London.

Website: https://brandessenceresearch.com
Blog: Pump Manufacturers in Global Market 2021
Sir. Vishal Sawant
E-mail: [email protected]
E-mail: [email protected]
Sales to businesses: + 44-2038074155
Asia office: +917447409162

SOURCE Brandessence Market Research And Consulting Private Limited

Comments are closed.